September 17: The Week in Cancer News
An immunotherapy combination continues to be effective in treating kidney cancer patients, and more news of the week from Cancer Today.
Progress Against Cancer
An immunotherapy combination continues to be effective in treating kidney cancer patients, and more news of the week from Cancer Today.
9/11 first responders’ cancer survival compares favorably to the general population, and more news of the week from Cancer Today.
Cancer is often described as a disease of old age, but over 15,000 children are diagnosed with cancer each year in the United States. While pediatric cancers tend to have higher survival rates than...
What if a machine could “think” like a doctor and diagnose and treat a disease? This is one of the long-term goals for the field of artificial intelligence (AI). In a session co-sponsored by the American Association for Cancer Research...
Regular exercise can help mitigate cognitive problems associated with chemotherapy, and more news of the week from Cancer Today.
Glioblastoma is an aggressive form of brain cancer. Less than 5 percent of patients diagnosed with this cancer type will survive for five years or more. Glioblastoma is notoriously difficult to treat, and new avenues...
Patient volume at radiation therapy clinics can affect outcomes, and more news of the week from Cancer Today.
Survival is not affected by delaying breast cancer treatment for fertility preservation, and more news of the week from Cancer Today.
The father of a child diagnosed with brain cancer calls for better financial support for families, and more news of the week from Cancer Today.
Two studies on access to opioids identify disturbing patterns, and more news of the week from Cancer Today.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now